Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients.
Gastric and colorectal cancers (GC and CRC) have poor prognosis and are resistant to chemo- and/or radiotherapy. In the present study, the prophylactic effects of dendritic cell (DC) vaccination are evaluated on disease progression and clinical benefits in a group of 54 GC and CRC patients treated w...
Guardado en:
Autores principales: | Daiqing Gao, Changyou Li, Xihe Xie, Peng Zhao, Xiaofang Wei, Weihong Sun, Hsin-Chen Liu, Aris T Alexandrou, Jennifer Jones, Ronghua Zhao, Jian Jian Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ee9a4cd2bb484e379082727dced72cde |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TNF-α and tumor lysate promote the maturation of dendritic cells for immunotherapy for advanced malignant bone and soft tissue tumors.
por: Shinji Miwa, et al.
Publicado: (2012) -
Comparison of four methods of colon cancer cell lysates preparation for ex vivo maturation of dendritic cells
por: Mohammad Roufarshbaf, et al.
Publicado: (2022) -
Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
por: Sara Nava, et al.
Publicado: (2021) -
Cytokine-induced memory-like natural killer cells for cancer immunotherapy
por: Mubin Tarannum, et al.
Publicado: (2021) -
Engineering dendritic cell vaccines to improve cancer immunotherapy
por: Caleb R. Perez, et al.
Publicado: (2019)